2013 Fiscal Year Final Research Report
Role of mTOR signaling pathway for the growth and proliferation of uterine leiomyoma
| Project/Area Number |
23592393
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
ISHIKAWA Hiroshi 千葉大学, 医学(系)研究科(研究院), 助教 (70553973)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SHOZU Makio 千葉大学, 大学院医学研究院, 教授 (30226302)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 子宮筋腫 / mTOR / 動物モデル / xenograft / 免疫不全マウス |
|---|
| Research Abstract |
We investigated the role of mammalian target of rapamycin (mTOR) signaling pathway for the growth and proliferation of uterine leimyoma; however, we did not find any overexpression of protein levels as well as mRNA levels of mTOR signaling pathway-related genes in uterine leiomyoma compared with those in myometrial tissues.
Next, we established a novel in vivo xenograft model for uterine leiomyoma, and evaluated its characters. The non-obese diabetic/severe combined immunodeficient murine xenograft model has shown a sex-steroid dependent growth of xenograft beneath the kidney capsule, a positive expression for both estrogen and progesterone receptors, and a similar representative gene expression compared with original leiomyoma tissue. In this model, we use only non-genetic manupilated primary cultured leiomyoma cells; therefore, we believe this model is a good tool for the research and the development of new therapies for uterine leiomyoma.
|
Research Products
(11 results)
